Cargando…

The Complement System: A Potential Therapeutic Target in Liver Cancer

Liver cancer is the sixth most common cancer and the fourth most fatal cancer in the world. Immunotherapy has already achieved modest results in the treatment of liver cancer. Meanwhile, the novel and optimal combinatorial strategies need further research. The complement system, which consists of me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Meng, Liu, Li, Wang, Chenlin, Zhang, Yan, Zhang, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604633/ https://www.ncbi.nlm.nih.gov/pubmed/36294966 http://dx.doi.org/10.3390/life12101532

Ejemplares similares

Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
por: Yuan, Meng, et al.
Publicado: (2023)

Complement as a Therapeutic Target in Systemic Autoimmune Diseases
por: Galindo-Izquierdo, María, et al.
Publicado: (2021)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

T lymphocyte cell: A pivotal player in lung cancer
por: Wu, Yanan, et al.
Publicado: (2023)

Complement System and Potential Therapeutics in Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2021)

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer
por: Wu, Yanan, et al.
Publicado: (2023)

Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
por: Hussain, Naushair, et al.
Publicado: (2022)

Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
por: Agostinis, Chiara, et al.
Publicado: (2021)

The complement system in liver diseases: Evidence-based approach and therapeutic options()
por: Lung, Thomas, et al.
Publicado: (2019)

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
por: Garred, Peter, et al.
Publicado: (2021)

Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
por: Barkoff, Courtney M., et al.
Publicado: (2020)

The Role of Complement System in Septic Shock
por: Charchaflieh, Jean, et al.
Publicado: (2012)

Roles of the complement system in alcohol-induced liver disease
por: Zhou, Yi, et al.
Publicado: (2020)

Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
por: Trambas, Inez A., et al.
Publicado: (2023)

The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer
por: Zhao, Ping, et al.
Publicado: (2019)

Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets
por: Liu, Bin, et al.
Publicado: (2013)

Correction to: The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer
por: Zhao, Ping, et al.
Publicado: (2019)

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
por: Meng, Yu, et al.
Publicado: (2022)

Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets
por: Ding, Ya-Hui, et al.
Publicado: (2017)

Identification of potential biomarkers and therapeutic targets for antineutrophil cytoplasmic antibody-associated glomerulonephritis
por: Wang, Yiru, et al.
Publicado: (2023)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

The Complement System, Aging, and Aging-Related Diseases
por: Zheng, Runzi, et al.
Publicado: (2022)

The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential
por: Zhang, Xue, et al.
Publicado: (2022)

USP10 as a Potential Therapeutic Target in Human Cancers
por: Tao, Li, et al.
Publicado: (2022)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
por: Li, Hai, et al.
Publicado: (2016)

The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
por: Querol, Luis A., et al.
Publicado: (2022)

Apelin/APJ system: A key therapeutic target for liver disease
por: Lv, Shuang-Yu, et al.
Publicado: (2017)

The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets
por: Cui, Jianzhou, et al.
Publicado: (2020)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Role of the complement system in the tumor microenvironment
por: Zhang, Ronghua, et al.
Publicado: (2019)

Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets
por: Cui, Chaochu, et al.
Publicado: (2021)

The pathogenesis and potential therapeutic targets in sepsis
por: Zhang, Wendan, et al.
Publicado: (2023)

Effects of the POMC System on Glucose Homeostasis and Potential Therapeutic Targets for Obesity and Diabetes
por: Yang, Dan, et al.
Publicado: (2022)

SUN2: A potential therapeutic target in cancer
por: Chen, Xin, et al.
Publicado: (2019)

Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
por: Qin, Shuqi, et al.
Publicado: (2021)

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
por: Kleczko, Emily K., et al.
Publicado: (2019)

Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
por: Geervliet, Eline, et al.
Publicado: (2020)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets
por: Wang, Zhanpeng, et al.
Publicado: (2016)

Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer
por: Li, Difeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p865tnakpv5glep653c1rm8u1c